Company: Sagent Pharmaceuticals
Based: Schaumberg, IL
Investors: Zhejiang Hisun Pharmaceutical and other undisclosed partners
Scoop: Sagent has set its sights firmly on China as it received $10 million from Zhejiang Hisun Pharmaceutical and another $30 million from "an unnamed China-focused private equity investment fund," according to a company release.
Sagent made 2007's VC list after a $53 million venture round. The company has raised $153 million total.